The ABCs for Life Sciences Entrepreneurs: From Start-Up to Exit

Thinking about starting or joining a life sciences company, now or in the future? If so, please join Morse, Barnes-Brown & Pendleton for a series of engaging and interactive discussions on the basic topics with which entrepreneurs in the life sciences today must be familiar. There will be four sessions, each covering a different topic: …

Continue reading The ABCs for Life Sciences Entrepreneurs: From Start-Up to Exit

Gene Patents Invalid in Early Action, But Game Far From Over

By: Lisa Treannie A federal judge in NY struck a blow to gene patents and methods of genetic analysis in this week's ruling in Association for Molecular Pathology and ACLU v. USPTO and Myriad (S.D.N.Y. 2010). Should the decision be upheld on appeal, it will have far reaching consequences, affecting thousands of issued patents and …

Continue reading Gene Patents Invalid in Early Action, But Game Far From Over

USPTO Extends Temporary Program Aimed at Reducing the Backlog of Unexamined Patent Applications

By: Stan Chalvire The U.S. Patent and Trademark Office (USPTO) recently extended its temporary initiative aimed at reducing the backlog of unexamined patent applications. The Patent Application Backlog Reduction Stimulus Plan, which was originally scheduled to remain in effect until February 28, 2010, has now been extended until June 30, 2010. As previously announced, the …

Continue reading USPTO Extends Temporary Program Aimed at Reducing the Backlog of Unexamined Patent Applications